COLL
COLL
US19459J1043
Collegium Pharmaceutical, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 780.567.000 631.449.000
23.6%
Cost of Revenue 317.310.000 254.105.000
24.9%
Gross Profit 463.257.000 377.344.000
22.8%
284.803.000 210.363.000
35.4%
Operating Income 178.454.000 166.981.000
6.9%
Pretax Income 92.619.000 98.568.000
6.0%
Net Income Common Stockholders 62.870.000 69.190.000
9.1%
-- --
--
-- --
--
ende